SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-19-109160
Filing Date
2019-04-17
Accepted
2019-04-17 16:33:03
Documents
9
Effectiveness Date
2019-04-17

Document Format Files

Seq Description Document Type Size
1 DEFA14A d632632ddefa14a.htm DEFA14A 28055
2 GRAPHIC g632632g17u40.jpg GRAPHIC 2171
3 GRAPHIC g632632g30y75.jpg GRAPHIC 20091
4 GRAPHIC g632632g47w63.jpg GRAPHIC 2687
5 GRAPHIC g632632g58y70.jpg GRAPHIC 339788
6 GRAPHIC g632632g65i73.jpg GRAPHIC 284392
7 GRAPHIC g632632g87t27.jpg GRAPHIC 2375
8 GRAPHIC g632632g92q86.jpg GRAPHIC 97907
9 GRAPHIC g632632g99f90.jpg GRAPHIC 317287
  Complete submission text file 0001193125-19-109160.txt   1499590
Mailing Address CLONSHAUGH BUSINESS AND TECHNOLOGY PARK COOLOCK, DUBLIN L2 D17 E400
Business Address CLONSHAUGH BUSINESS AND TECHNOLOGY PARK COOLOCK, DUBLIN L2 D17 E400 (216) 523-5000
Allergan plc (Filer) CIK: 0001578845 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36867 | Film No.: 19753371
SIC: 2834 Pharmaceutical Preparations